ALP Bio AG
PrivateLast Round
Grant
Jul 3, 2026
Total Funding Raised
$2.39M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ALP Bio AG is a biotechnology company developing an immune organoid and AI platform for immunogenicity intelligence in biologics development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ALP Bio AG Comparables
Compare ALP Bio AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EpiVax | 76% | |
| ProImmune Ltd | 74% | |
| Parallel Bio | 71% |
ALP Bio AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 3, 2026 | ||||
| Pre Seed | Apr 30, 2026 |
ALP Bio AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 42CAP | Pre Seed |
| Venture Kick | Grant, Pre Seed |
| Ajira Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 3, 2026
$187K grant received from Venture Kick.
- Apr 30, 2026
$2.2M round led by 42CAP.
Recent news
Latest coverage and updates
- is_developingSep 28, 2026
Alp Bio AG is developing immunogenicity-intelligence platform for biologic drugs.
- is_developingJul 3, 2026
Alp Bio AG is developing AI-powered platform.
- receives_financingJul 3, 2026
Alp Bio AG received financing of $184K in Seed on Jul 3rd '26.
ALP Bio AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ALP Bio AG's valuation, stock price, and market status.
Is ALP Bio AG a public or private company?
ALP Bio AG is a private company.
What is the current stock price of ALP Bio AG?
ALP Bio AG is a private company with no public stock price. No recent secondary market data is available.
How much is ALP Bio AG worth (valuation)?
Valuation information for ALP Bio AG is not publicly available.
Can I buy ALP Bio AG stock?
ALP Bio AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ALP Bio AG's last funding round?
ALP Bio AG's most recent funding round was Pre Seed on April 30, 2026.
Who are the main investors in ALP Bio AG?
Key investors in ALP Bio AG include 42CAP.
Will ALP Bio AG IPO soon?
No public IPO plans have been announced for ALP Bio AG.
How can I track ALP Bio AG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ALP Bio AG's secondary market activity and sign up for updates.